Duke Capital Partners

Xilis, Inc. is an oncology and precision health company that focuses on improving cancer diagnosis and treatment. Founded in 2019 and based in Chapel Hill, North Carolina, Xilis utilizes advanced organoid technologies, specifically micro-organoids, to create thousands of 3D replicas of a patient's tumor within six days. This innovative approach allows for rapid diagnostics and personalized drug screening, enabling healthcare providers to identify the most effective treatments for individual patients. The company's platform supports scalable, patient-derived models that facilitate high-throughput drug discovery, ultimately assisting physicians and pharmaceutical companies in developing tailored therapies at a reduced cost.

Xilis, Inc. is an oncology and precision health company that focuses on improving cancer diagnosis and treatment. Founded in 2019 and based in Chapel Hill, North Carolina, Xilis utilizes advanced organoid technologies, specifically micro-organoids, to create thousands of 3D replicas of a patient's tumor within six days. This innovative approach allows for rapid diagnostics and personalized drug screening, enabling healthcare providers to identify the most effective treatments for individual patients. The company's platform supports scalable, patient-derived models that facilitate high-throughput drug discovery, ultimately assisting physicians and pharmaceutical companies in developing tailored therapies at a reduced cost.

EternaTear, Inc. is focused on developing an innovative artificial tear solution aimed at addressing the challenges of dry eye syndrome. Based in Raleigh, North Carolina, the company has created EternaTear, a product designed to provide lubrication and therapeutic relief for individuals suffering from progressive dry eye. The solution utilizes a proprietary mechanism to supplement and bind the three layers of the tear film, enhancing stability and prolonging its presence on the ocular surface. This approach aims to mitigate the inadequate relief provided by existing over-the-counter options, which often require frequent reapplication and do not address the underlying causes of dry eye. By combining established technologies with novel research, EternaTear seeks to offer a more effective treatment that can significantly improve patients' quality of life and reduce symptoms associated with this condition.

restor3d enables surgeons to improve the reconstruction and repair of the human body through 3D printed implants.

Carpe specializes in the production of an over-the-counter antiperspirant lotion designed specifically for hands and feet. The product is dermatologist-recommended, clinically proven, and formulated to effectively reduce sweat without causing irritation. Carpe's lotion is characterized as non-greasy and leaves no residue, making it user-friendly. Additionally, the formulation includes natural eucalyptus oil, which enhances the application experience by providing a smooth feel. This innovative solution addresses the common issue of excessive sweating in a safe and effective manner, catering to individuals seeking relief from sweaty hands and feet.

Tyrata, Inc. is a sensor development and data management company based in Durham, North Carolina, with additional offices in Germany and Japan. Founded in 2015, Tyrata specializes in proprietary wireless sensors and systems that provide real-time monitoring and reporting of vehicular tire tread wear. Its patented IntelliTread technology allows for the tracking and prediction of tire tread wear throughout the lifespan of any tire. The company's solutions cater to consumers, fleet management companies, and high-performance specialists who prioritize tire integrity for safety, efficiency, and profitability. By offering historical tire tread wear information, Tyrata enables clients to make tire maintenance predictable and informed.

Alievio is a North Carolina-based innovative glaucoma medical device company. The company has introduced the first glaucoma therapy that will not only circumvent the complications present with glaucoma surgery. It also provides ophthalmologists with the first tool that can stop the progression of glaucoma.

Mati Inc. is a company based in Durham, North Carolina, that specializes in the production and sale of energy drinks. Founded in 2012, it offers a unique energy drink brewed from plant-based ingredients, fruit juice concentrates, and water. The flagship product, MATI, is designed to provide a healthier alternative for active and health-conscious consumers seeking to enhance their everyday performance. Mati Inc. distributes its products through various channels, including wholesalers, retail outlets, and online platforms, primarily serving customers in North Carolina and surrounding counties. As of April 2020, Mati Inc. operates as a subsidiary of NOBL Beverages.

410 Medical is a healthcare company based in Durham, North Carolina, founded in 2013. It specializes in developing a rapid infuser device designed to assist critically ill patients who require volume resuscitation. This innovative solution enables healthcare providers to quickly deliver fluids, including blood and other essential components, thereby enhancing the speed and efficiency of care for patients facing life-threatening conditions like sepsis and shock. The device allows for fast setup and minimizes provider fatigue, enabling a single healthcare provider to manage multiple patient care issues simultaneously. It is particularly beneficial in pre-hospital settings and emergency departments, where timely intervention is crucial and resources may be constrained.

InnAVasc Medical, Inc. is a medical device company based in Durham, North Carolina, focused on developing innovative solutions for vascular access in hemodialysis. Founded by surgeons from Duke University, the company has created the Bullet Proof Vascular Access Graft, an advanced arteriovenous graft designed with two multilayer cannulation chambers. This technology features low bleed capabilities and is engineered to resist posterior and sidewall needle penetration, thereby minimizing the risk of needle cannulation injuries. By modifying existing synthetic vascular grafts, InnAVasc aims to enhance immediate hemodialysis access and improve graft access safety, ultimately reducing the likelihood of adverse events and device failures associated with repeated vascular access procedures.

Fathom AI is a developer of a predictive analytics platform designed for fitness content providers. The platform utilizes bio-data-driven personalization to enhance user engagement by recommending tailored daily workouts and recovery activities based on individual user metrics. By combining sports science, predictive analytics, and user experience design, Fathom AI enables content providers to curate personalized fitness experiences that also include injury prevention strategies. This approach not only fosters user engagement and brand trust but also supports users in their fitness journeys, helping them achieve self-mastery and maintain better health outcomes.

Mati Inc. is a company based in Durham, North Carolina, that specializes in the production and sale of energy drinks. Founded in 2012, it offers a unique energy drink brewed from plant-based ingredients, fruit juice concentrates, and water. The flagship product, MATI, is designed to provide a healthier alternative for active and health-conscious consumers seeking to enhance their everyday performance. Mati Inc. distributes its products through various channels, including wholesalers, retail outlets, and online platforms, primarily serving customers in North Carolina and surrounding counties. As of April 2020, Mati Inc. operates as a subsidiary of NOBL Beverages.

GoldenKey, Inc. develops and operates a community platform that connects home buyers and sellers with a nationwide community of real estate agents. The company operates an interactive online marketplace for home buyers and connects them with real estate professionals to search for homes and get rebate on their home purchase. GoldenKey, Inc. was formerly known as SoloPro, Inc. and changed its name to GoldenKey, Inc. in September 2016. The company was incorporated in 2015 and is based in Durham, North Carolina. As of September 4, 2018, GoldenKey, Inc. operates as a subsidiary of Landis Technologies Inc.

Baebies, Inc. is a company that focuses on manufacturing screening and pediatric testing equipment for newborns. Established in 2014 and based in Durham, North Carolina, Baebies produces SEEKER, a laboratory solution for newborn screening that conducts multiple assays simultaneously by measuring lysosomal enzyme activity from a single dried blood spot. Additionally, the company offers FINDER, a near-patient testing device designed for pediatric applications. Baebies aims to enhance early disease detection and improve diagnostic capabilities through its innovative digital microfluidics technology, which optimizes the diagnostic yield from minimal blood samples. The company serves hospitals and public health laboratories, with a mission dedicated to saving lives and improving health outcomes for children by providing advanced testing solutions.

Baebies, Inc. is a company that focuses on manufacturing screening and pediatric testing equipment for newborns. Established in 2014 and based in Durham, North Carolina, Baebies produces SEEKER, a laboratory solution for newborn screening that conducts multiple assays simultaneously by measuring lysosomal enzyme activity from a single dried blood spot. Additionally, the company offers FINDER, a near-patient testing device designed for pediatric applications. Baebies aims to enhance early disease detection and improve diagnostic capabilities through its innovative digital microfluidics technology, which optimizes the diagnostic yield from minimal blood samples. The company serves hospitals and public health laboratories, with a mission dedicated to saving lives and improving health outcomes for children by providing advanced testing solutions.